SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-327683
Filing Date
2020-12-28
Accepted
2020-12-28 16:31:00
Documents
3
Group Members
ARTAL GROUP S.A.ARTAL INTERNATIONAL MANAGEMENT S.A.ARTAL TREASURY LTDINVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.MR. PASCAL MINNESTICHTING ADMINISTRATIEKANTOOR WESTENDWESTEND S.A.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d101381dsc13g.htm SC 13G 150633
2 EXHIBIT 1 d101381dex991.htm EX-99.1 11672
3 EXHIBIT 2 d101381dex992.htm EX-99.2 4599
  Complete submission text file 0001193125-20-327683.txt   168998
Mailing Address VALLEY PARK 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661
Business Address VALLEY PARK 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661 352224259-1
Artal International S.C.A. (Filed by) CIK: 0001218180 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Subject) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90188 | Film No.: 201418696
SIC: 2834 Pharmaceutical Preparations